COPD

News

Mylan launches Advair generic at 70% discount in US

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug.

News

AZ's new COPD inhaler Bevespi Aerosphere approved in EU

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive pulmonary disease (COPD).

News

AZ COPD drug fails to match GSK rival after disappointing la...

AstraZeneca has said it is analysing “inconsistent” results after a late-stage trial of its Bevespi Aerosphere inhaler in chronic obstructive pulmonary disease (COPD) failed to match the pe

News

GSK's Nucala unlikely to get COPD use after panel vote

FDA due to make decision in September

News

NICE restricts use of antibiotics in draft COPD guidance

NICE has published draft guidance restricting use of antibiotics in patients with chronic obstructive pulmonary disease (COPD), as in many cases the treatment is inappropriate and could lea

News

AstraZeneca’s respiratory biologic fails again in COPD

AstraZeneca (AZ) and MedImmune, have announced that the latest trial of Fasenra (benralizumab) in patients with moderate-to-very-severe chronic obstructive pulmonary disease (COPD) did not provide a statistically-significant reduction in exacerbations.

Mylan launches Advair generic at 70% discount in US

AZ's new COPD inhaler Bevespi Aerosphere approved in EU

AZ COPD drug fails to match GSK rival after disappointing la...

GSK's Nucala unlikely to get COPD use after panel vote

NICE restricts use of antibiotics in draft COPD guidance

AstraZeneca’s respiratory biologic fails again in COPD

Setback for MSD as German court blocks Keytruda SC launch

How to meet your physicians where they are online

COPD

Editor's Picks